Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

Glucagon-like peptide 1 [7-36 amide] (GLP-1) has been shown to enhance insulin secretion in healthy and type II diabetic humans, and to increase glucose disposal in type I diabetic patients. To further define its action on glucose kinetics, we studied six healthy subjects who received either GLP-1 (...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	J Clin Invest
Principais autores:	D'Alessio, D A, Kahn, S E, Leusner, C R, Ensinck, J W
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Clinical Investigation 1994
נושאים:	Research Article
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC294382/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8182159/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117225
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!